NEW ORLEANS, Nov. 10 CorMatrix Cardiovascular, Inc., anAtlanta-based company dedicated to developing and delivering uniqueextracellular matrix (ECM(TM)) biomaterial devices that harness the ...
Fibrosis, resulting from excess extracellular matrix (ECM) deposition, is a feature of adipose tissue (AT) dysfunction and obesity-related insulin resistance. Emerging evidence indicates that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results